SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-004371
Filing Date
2023-06-23
Accepted
2023-06-23 06:00:16
Documents
13
Period of Report
2023-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cannapharmarx_8k.htm   iXBRL 8-K 29204
2 EMPLOYMENT AGREEMENT cannapharmarx_ex1001.htm EX-10.1 7394
  Complete submission text file 0001683168-23-004371.txt   216449

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cpmd-20230601.xsd EX-101.SCH 2974
4 XBRL LABEL FILE cpmd-20230601_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cpmd-20230601_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT cannapharmarx_8k_htm.xml XML 3680
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 231034810
SIC: 2834 Pharmaceutical Preparations